Kilian Kelly

Kilian Kelly

Director Ejecutivo en CYNATA THERAPEUTICS LIMITED .

Fortuna: 71 658 $ al 30/04/2024

Commercial Services
Health Technology
Consumer Services

Perfil

Kilian Kelly is currently the Chief Executive Officer & Managing Director at Cynata Therapeutics Ltd.
He is also a Member of the Regulatory Affairs Professionals Society, the Royal Pharmaceutical Society of Great Britain, the International Society for Cellular Therapy, the Australian Institute of Co. Directors, and The Organisation for Professionals in Regulatory Affairs Ltd.
In the past, Dr. Kelly held the position of Senior Director-Drug Development at Aviragen Therapeutics, Inc. and Vice President-Regulatory & Clinical at Mesoblast Ltd.
Dr. Kelly obtained a doctorate degree from the University of Strathclyde and a graduate degree from The Robert Gordon University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
30/06/2023 525 508 ( 0.29% ) 71 658 $ 30/04/2024

Cargos activos de Kilian Kelly

EmpresasCargoInicio
CYNATA THERAPEUTICS LIMITED Director Ejecutivo 01/07/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Todos los cargos activos de Kilian Kelly

Antiguos cargos conocidos de Kilian Kelly.

EmpresasCargoFin
MESOBLAST LIMITED Director Técnico/Científico/I+D -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Kilian Kelly.

Formación de Kilian Kelly.

The Robert Gordon University Graduate Degree
University of Strathclyde Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kilian Kelly.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
CYNATA THERAPEUTICS LIMITED

Health Technology

MESOBLAST LIMITED

Health Technology

Empresas privadas6

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA